Skip to main content

Table 2 Results of cost analysis of glatiramer acetate versus fingolimod

From: Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain

 

GA

Fingolimod

GA-Fingolimod

Pharmacological cost

€9,420.34

€19,292.86

€-9,872.52

Administration cost

€19.08

€0.00

€19.08

Cost of infection management

€0.00

€22.97

€-22.97

Cost of prevention of macular edema

€0.00

€113.64

€-113.64

Cost of liver function monitoring

€0.00

€14.79

€-14.79

Cost of cardiovascular monitoring

€0.00

€157.93

€-157.93

TOTAL COST PER PATIENT/YEAR

€9,439.42

€19,602.18

€-10,162.76

  1. GA, Glatiramer acetate.